Tauriga Sciences Inc. (TAUG) Appoints Mr. Michael Wolff as the Fifth Member of the Company's Board of Directors; Company's Board Now Sarbanes-Oxley Compliant
5/15/2013 9:03:26 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK, May 15, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"), a life sciences company creating a diversified portfolio of medical technology assets, has today announced the appointment of Mr. Michael Wolff ("Mr. Wolff") as the fifth member of the Company's Board of Directors ("Board"). Mr. Wolff will serve the Company as an independent member of the Board and will help the Company with the composition of the recently established Board oversight committees. In his capacity as an independent director, Mr. Wolff will assist in the Company in further enhancing its corporate governance protocols and oversight committees, as well making his impressive rolodex available to management. With the appointment of Mr. Wolff as the Company's fifth Board member (third independent director), the Company has now become Sarbanes-Oxley ("SOX") compliant, with respect to the composition of its corporate Board.
Help employers find you! Check out all the jobs and post your resume.